"Utilization and cost of bexarotene in the Medicare population: 2013 to 2017." Journal of Dermatological Treatment, 33(4), pp. 2400–2401
Ethical approval
This study did not involve human subjects and utilized publicly available data. Yale University institutional review board approval was not required.
Disclosure statement
No potential conflict of interest was reported by the author(s).